CoChat
Sign Up
Cited by 31

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis

Rivero-Ríos, Pilar, Romo-Lozano, María, Fasiczka, Rachel, Naaldijk, Yahaira, Hilfiker, Sabine·2020·Frontiers in Neuroscience
DOI 10.3389/fnins.2020.00556PMC PMC7287096
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2020.00556

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 172

  1. Agin-Liebes, 2019, Movement disorders rounds: a case of missing pathology in a patient with LRRK2 Parkinson’s disease., Parkinsonism Relat. Disord., 10.1016/j.parkreldis.2019.11.006 · DOI
  2. Akgoc, 2015, Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses., J. Lipid Res., 56, 1006, 10.1194/jlr.M057851 · DOI
  3. Alcalay, 2020, Higher urine bis(Monoacylglycerol)phosphate levels in LRRK2 G2019S mutation carriers: implications for therapeutic development., Mov. Disord., 35, 134, 10.1002/mds.27818 · DOI
  4. Alegre-Abarrategui, 2009, LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model., Hum. Mol. Genet., 18, 4022, 10.1093/hmg/ddp346 · DOI
  5. Anand, 2009, Investigation of leucine-rich repeat kinase 2., FEBS J., 276, 466, 10.1111/j.1742-4658.2008.06789.x · DOI
  6. Anderson, 2006, Phosphorylation of ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease., J. Biol. Chem., 281, 29739, 10.1074/jbc.M600933200 · DOI
  7. Beilina, 2014, Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease., Proc. Natl. Acad. Sci. U.S.A., 111, 2626, 10.1073/pnas.1318306111 · DOI · Paper page
  8. Berg, 2014, Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson’s disease., Mov. Disord., 29, 454, 10.1002/mds.25844 · DOI
  9. Billingsley, 2018, Genetic risk factors in Parkinson’s disease., Cell Tissue Res., 373, 9, 10.1007/s00441-018-2817-y · DOI
  10. Boassa, 2013, Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson’s disease pathogenesis., J. Neurosci., 33, 2605, 10.1523/JNEUROSCI.2898-12.2013 · DOI
  11. Bonet-Ponce, 2020, LRRK2 mediates tubulation and vesicle sorting from membrane damaged lysosomes., bioRxiv, 10.1101/2020.01.23.917252 · DOI
  12. Book, 2018, A meta-analysis of α-synuclein multiplication in familial parkinsonism., Front. Neurol., 9, 10.3389/fneur.2018.01021 · DOI
  13. Braak, 2003, Staging of brain pathology related to sporadic Parkinson’s disease., Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
  14. Braun, 2015, The Rho-specific GAP protein DLC3 coordinates endocytic membrane trafficking., J. Cell Sci., 128, 1386, 10.1242/jcs.163857 · DOI · Paper page
  15. Bravo-San Pedro, 2013, The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway., Cell. Mol. Life Sci., 70, 121, 10.1007/s00018-012-1061-y · DOI
  16. Brice, 2005, Genetics of Parkinson’s disease: LRRK2 on the rise., Brain, 128, 2760, 10.1093/brain/awh676 · DOI
  17. Bridi, 2018, Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson’s disease., Front. Neurosci., 12, 10.3389/fnins.2018.00080 · DOI
  18. Bucci, 2012, Molecular basis of charcot-marie-tooth type 2B disease., Biochem. Soc. Trans, 40, 1368, 10.1042/BST20120197 · DOI
  19. Bucci, 2000, Rab7: a key to lysosome biogenesis., Mol. Biol. Cell, 11, 467, 10.1091/mbc.11.2.467 · DOI
  20. Burré, 2010, Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro., Science, 329, 1663, 10.1126/science.1195227 · DOI
  21. Burton, 1994, Specific interactions of Mss4 with members of the Rab GTPase subfamily., EMBO J., 13, 5547, 10.1002/j.1460-2075.1994.tb06892.x · DOI
  22. Caballero, 2018, Interplay of pathogenic forms of human tau with different autophagic pathways., Aging Cell, 17, 10.1111/acel.12692 · DOI · Paper page
  23. Ceresa, 2006, Rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome., J. Biol. Chem., 281, 1099, 10.1074/jbc.M504175200 · DOI
  24. Cherra, 2013, Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons., Am. J. Pathol., 182, 474, 10.1016/j.ajpath.2012.10.027 · DOI
  25. Cherry, 2013, Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function., eLife, 2, 10.7554/eLife.01064 · DOI
  26. Choudhury, 2002, Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells., J. Clin. Invest., 109, 1541, 10.1172/JCI0215420 · DOI
  27. Choudhury, 2004, Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling., Mol. Biol. Cell, 15, 4500, 10.1091/mbc.e04-05-0432 · DOI
  28. Christensen, 2018, LRRK2 exonic variants associated with Parkinson’s disease augment phosphorylation levels for LRRK2-Ser1292 and Rab10-Thr73., bioRxiv, 10.1101/447946 · DOI
  29. Cogo, 2020, Leucine-rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease., J. Neurochem., 152, 273, 10.1111/jnc.14908 · DOI
  30. Cole, 2002, Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein α-synuclein., J. Biol. Chem., 277, 6344, 10.1074/jbc.M108414200 · DOI · Paper page
  31. Conway, 2000, Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy., Proc. Natl. Acad. Sci. U.S.A., 97, 571, 10.1073/pnas.97.2.571 · DOI
  32. Covy, 2009, Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2., Biochem. Biophys. Res. Commun., 378, 473, 10.1016/j.bbrc.2008.11.048 · DOI
  33. Cuervo, 2004, Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy., Science, 305, 1292, 10.1126/science.1101738 · DOI · Paper page
  34. Cuervo, 2013, Chaperone-mediated autophagy: roles in disease and aging., Cell Res., 24, 92, 10.1038/cr.2013.153 · DOI
  35. Danzer, 2012, Exosomal cell-to-cell transmission of alpha synuclein oligomers., Mol. Neurodegener., 7, 10.1186/1750-1326-7-42 · DOI
  36. Danzer, 2009, Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology., J. Neurochem., 111, 192, 10.1111/j.1471-4159.2009.06324.x · DOI · Paper page
  37. Davidson, 1998, Stabilization of α-synuclein secondary structure upon binding to synthetic membranes., J. Biol. Chem., 273, 9443, 10.1074/jbc.273.16.9443 · DOI
  38. Devergne, 2017, Stratum, a homolog of the human GEF Mss4, partnered with Rab8, controls the basal restriction of basement membrane proteins in epithelial cells., Cell Rep., 18, 1831, 10.1016/j.celrep.2017.02.002 · DOI
  39. Di Fonzo, 2006, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson’s disease., Eur. J. Hum. Genet, 14, 322, 10.1038/sj.ejhg.5201539 · DOI
  40. Do, 2019, Glucocerebrosidase and its relevance to Parkinson disease., Mol. Neurodegener, 14, 10.1186/s13024-019-0336-2 · DOI
  41. Dodson, 2012, Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning., Hum. Mol. Genet., 21, 1350, 10.1093/hmg/ddr573 · DOI
  42. Eguchi, 2018, LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis., Proc. Natl. Acad. Sci. U.S.A., 115, E9115, 10.1073/pnas.1812196115 · DOI
  43. Follmer, 2015, Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of α-synuclein with the toxic dopamine metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)., J. Biol. Chem., 290, 27660, 10.1074/jbc.M115.686584 · DOI
  44. Foo, 2013, A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson’s disease., Neurobiol. Aging, 34, 2890.e13, 10.1016/j.neurobiolaging.2013.06.010 · DOI
  45. Fortin, 2004, Lipid rafts mediate the synaptic localization of alpha-synuclein., J. Neurosci., 24, 6715, 10.1523/JNEUROSCI.1594-04.2004 · DOI
  46. Gan-Or, 2013, The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease., Neurology, 80, 1606, 10.1212/WNL.0b013e31828f180e · DOI
  47. Garrido, 2019, α-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson’s disease., Ann. Clin. Transl. Neurol., 6, 1024, 10.1002/acn3.772 · DOI
  48. Gasser, 2015, Usefulness of genetic testing in PD and PD trials: a balanced review., J. Parkinsons. Dis., 5, 209, 10.3233/JPD-140507 · DOI
  49. Giasson, 2000, Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions., Science, 290, 985, 10.1126/science.290.5493.985 · DOI
  50. Gilks, 2005, A common LRRK2 mutation in idiopathic Parkinson’s disease., Lancet, 365, 415, 10.1016/S0140-6736(05)17830-1 · DOI · Paper page
  51. Gloeckner, 2006, The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity., Hum. Mol. Genet., 15, 223, 10.1093/hmg/ddi439 · DOI
  52. Goldwurm, 2007, Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease., Neurology, 68, 1141, 10.1212/01.wnl.0000254483.19854.ef · DOI
  53. Gomez, 2019, Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases., J. Cell Biol., 218, 4157, 10.1083/jcb.201902184 · DOI · Paper page
  54. Gómez-Suaga, 2012, Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP., Hum. Mol. Genet., 21, 511, 10.1093/hmg/ddr481 · DOI
  55. Gómez-Suaga, 2014, LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity., Hum. Mol. Genet., 23, 6779, 10.1093/hmg/ddu395 · DOI · Paper page
  56. Greggio, 2009, Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions., ASN Neuro, 1, 10.1042/AN20090007 · DOI
  57. Greggio, 2006, Kinase activity is required for the toxic effects of mutant LRRK2/dardarin., Neurobiol. Dis., 23, 329, 10.1016/j.nbd.2006.04.001 · DOI · Paper page
  58. Greggio, 2007, Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1., J. Neurochem., 102, 93, 10.1111/j.1471-4159.2007.04523.x · DOI
  59. Guo, 2007, The Parkinson’s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activity., Exp. Cell Res., 313, 3658, 10.1016/j.yexcr.2007.07.007 · DOI
  60. Hallett, 2018, Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain., Neurobiol. Aging, 67, 189, 10.1016/j.neurobiolaging.2018.02.028 · DOI
  61. Halliday, 2012, Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson’s disease?, Expert Rev. Neurother., 12, 673, 10.1586/ern.12.47 · DOI
  62. Hanafusa, 2019, LRRK1 phosphorylation of Rab7 at S72 links trafficking of EGFR-containing endosomes to its effector RILP., J. Cell Sci., 132, 10.1242/jcs.228809 · DOI
  63. Hattula, 2002, A Rab8-specific GDP/GTP exchange factor is involved in actin remodeling and polarized membrane transport., Mol. Biol. Cell, 13, 3268, 10.1091/mbc.E02-03-0143 · DOI
  64. Hattula, 2006, Characterization of the Rab8-specific membrane traffic route linked to protrusion formation., J. Cell Sci., 119, 4866, 10.1242/jcs.03275 · DOI
  65. Hein, 2013, Selective reduction of bis(monoacylglycero)phosphate ameliorates the storage burden in a THP-1 macrophage model of Gaucher disease., J. Lipid Res., 54, 1691, 10.1194/jlr.M038232 · DOI
  66. Henderson, 2019, Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease., Acta Neuropathol. Commun., 7, 10.1186/s40478-019-0836-x · DOI
  67. Hobert, 2007, A novel role of the Batten disease gene CLN3: association with BMP synthesis., Biochem. Biophys. Res. Commun., 358, 111, 10.1016/j.bbrc.2007.04.064 · DOI
  68. Hockey, 2015, Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition., J. Cell Sci., 128, 232, 10.1242/jcs.164152 · DOI
  69. Houlden, 2004, A novel RAB7 mutation associated with ulcero-mutilating neuropathy., Ann Neurol, 56, 586, 10.1002/ana.20281 · DOI
  70. Hsieh, 2016, Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson’s disease., Cell Stem Cell, 19, 709, 10.1016/j.stem.2016.08.002 · DOI
  71. Iaccarino, 2007, Apoptotic mechanisms in mutant LRRK2-mediated cell death., Hum. Mol. Genet., 16, 1319, 10.1093/hmg/ddm080 · DOI
  72. Imai, 2008, Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila., EMBO J., 27, 2432, 10.1038/emboj.2008.163 · DOI
  73. Ingelsson, 2016, Alpha-synuclein oligomers-neurotoxic molecules in Parkinson’s disease and other Lewy body disorders., Front. Neurosci., 10, 10.3389/fnins.2016.00408 · DOI · Paper page
  74. Islam, 2017, Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation., Biochem. Soc. Trans., 45, 163, 10.1042/BST20160264 · DOI
  75. Itoh, 2006, Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity., Genes Cells, 11, 1023, 10.1111/j.1365-2443.2006.00997.x · DOI
  76. Jäger, 2004, Role for Rab7 in maturation of late autophagic vacuoles., J. Cell Sci., 117, 4837, 10.1242/jcs.01370 · DOI
  77. Jaleel, 2007, LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson’s disease mutants affect kinase activity., Biochem. J., 405, 307, 10.1042/BJ20070209 · DOI · Paper page
  78. Jeong, 2018, Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration., Mol. Neurodegener., 13, 10.1186/s13024-018-0240-1 · DOI
  79. Jimenez-Orgaz, 2018, Control of RAB7 activity and localization through the retromer-TBC1D5 complex enables RAB7-dependent mitophagy., EMBO J., 37, 235, 10.15252/embj.201797128 · DOI · Paper page
  80. Jordens, 2001, The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors., Curr. Biol., 11, 1680, 10.1016/S0960-9822(01)00531-0 · DOI · Paper page
  81. Käkelä, 2003, Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry., J. Neurochem., 84, 1051, 10.1046/j.1471-4159.2003.01602.x · DOI
  82. Kalia, 2019, Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson’s disease”., Parkinsonism Relat. Disord., 10.1016/j.parkreldis.2019.11.005 · DOI
  83. Kalia, 2015, Parkinson’s disease., Lancet, 386, 896, 10.1016/S0140-6736(14)61393-3 · DOI · Paper page
  84. Kalia, 2015, Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease., JAMA Neurol., 72, 100, 10.1001/jamaneurol.2014.2704 · DOI
  85. Kim, 2017, The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking., Hum. Mol. Genet., 26, 729, 10.1093/hmg/ddw413 · DOI
  86. Kim, 2014, Alpha-synuclein biology in Lewy body diseases., Alzheimers Res. Ther., 6, 10.1186/s13195-014-0073-2 · DOI
  87. Klemann, 2017, Integrated molecular landscape of Parkinson’s disease., NPJ Parkinsons Dis., 3, 10.1038/s41531-017-0015-3 · DOI
  88. Korecka, 2019, Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson’s disease patient fibroblasts., Hum. Mol. Genet., 28, 3232, 10.1093/hmg/ddz126 · DOI
  89. Lebrand, 2002, Late endosome motility depends on lipids via the small GTPase Rab7., EMBO J., 21, 1289, 10.1093/emboj/21.6.1289 · DOI
  90. Lee, 2004, Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway., J. Neurosci., 24, 1888, 10.1523/JNEUROSCI.3809-03.2004 · DOI · Paper page
  91. Lemasters, 2014, Variants of mitochondrial autophagy: types 1 and 2 mitophagy and micromitophagy (Type 3)., Redox Biol., 2, 749, 10.1016/j.redox.2014.06.004 · DOI
  92. Leng, 2001, Muscarinic receptor stimulation induces translocation of an α-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm., J. Biol. Chem., 276, 28212, 10.1074/jbc.M011121200 · DOI
  93. Lesage, 2006, LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs., N. Engl. J. Med, 354, 422, 10.1056/NEJMc055540 · DOI · Paper page
  94. Lewis, 2007, The R1441C mutation of LRRK2 disrupts GTP hydrolysis., Biochem. Biophys. Res. Commun., 357, 668, 10.1016/j.bbrc.2007.04.006 · DOI
  95. Linder, 2007, Rab8-dependent recycling promotes endosomal cholesterol removal in normal and sphingolipidosis cells., Mol. Biol. Cell, 18, 47, 10.1091/mbc.E06-07-0575 · DOI
  96. Liu, 2011, A novel molecular mechanism for nitrated α-synuclein-induced cell death., J. Mol. Cell Biol., 3, 239, 10.1093/jmcb/mjr011 · DOI
  97. Luzón-Toro, 2007, Mechanistic insight into the dominant mode of the Parkinson’s disease-associated G2019S LRRK2 mutation., Hum. Mol. Genet., 16, 2031, 10.1093/hmg/ddm151 · DOI · Paper page
  98. MacLeod, 2006, The Familial Parkinsonism gene LRRK2 regulates neurite process morphology., Neuron, 52, 587, 10.1016/j.neuron.2006.10.008 · DOI
  99. MacLeod, 2013, RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk., Neuron, 77, 425, 10.1016/j.neuron.2012.11.033 · DOI · Paper page
  100. Madero-Pérez, 2018, Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation., Mol. Neurodegener., 13, 1, 10.1186/s13024-018-0235-y · DOI
  101. Manzoni, 2017, The LRRK2–macroautophagy axis and its relevance to Parkinson’s disease., Biochem. Soc. Trans., 45, 155, 10.1042/BST20160265 · DOI
  102. Manzoni, 2013, Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation., Biochem. Biophys. Res. Commun., 441, 862, 10.1016/j.bbrc.2013.10.159 · DOI
  103. Markesbery, 2009, Lewy body pathology in normal elderly subjects., J. Neuropathol. Exp. Neurol., 68, 816, 10.1097/NEN.0b013e3181ac10a7 · DOI · Paper page
  104. Martinez-Vicente, 2008, Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy., J. Clin. Invest., 118, 777, 10.1172/JCI32806 · DOI
  105. Meggouh, 2006, Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene., Neurology, 67, 1476, 10.1212/01.wnl.0000240068.21499.f5 · DOI
  106. Mukherjee, 2016, Selective endosomal microautophagy is starvation-inducible in Drosophila., Autophagy, 12, 1984, 10.1080/15548627.2016.1208887 · DOI
  107. Murphy, 2000, Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons., J. Neurosci., 20, 3214, 10.1523/JNEUROSCI.20-09-03214.2000 · DOI
  108. Nelson, 2014, Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice., Acta Neuropathol. Commun., 2, 10.1186/2051-5960-2-20 · DOI
  109. Nordmann, 2010, The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 homolog Ypt7., Curr. Biol., 20, 1654, 10.1016/j.cub.2010.08.002 · DOI
  110. Ozelius, 2006, LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews., N. Engl. J. Med, 354, 424, 10.1056/NEJMc055509 · DOI
  111. Pagano, 2003, Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases., Philos. Trans. R. Soc. Lond. B. Biol. Sci., 358, 885, 10.1098/rstb.2003.1275 · DOI
  112. Park, 2011, Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson’s disease., J. Clin. Neurol., 7, 215, 10.3988/jcn.2011.7.4.215 · DOI
  113. Pellegrini, 2018, Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice., Hum. Mol. Genet., 27, 3257, 10.1093/hmg/ddy232 · DOI
  114. Peng, 2018, Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies., Neurobiol. Dis., 109, 209, 10.1016/j.nbd.2017.07.018 · DOI
  115. Peralta, 2010, Differential effects of TBC1D15 and mammalian Vps39 on Rab7 activation state, lysosomal morphology, and growth factor dependence., J. Biol. Chem., 285, 16814, 10.1074/jbc.M110.111633 · DOI
  116. Peränen, 2011, Rab8 GTPase as a regulator of cell shape., Cytoskeleton, 68, 527, 10.1002/cm.20529 · DOI
  117. Plowey, 2008, Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells., J. Neurochem., 105, 1048, 10.1111/j.1471-4159.2008.05217.x · DOI
  118. Poulopoulos, 2012, The neuropathology of genetic Parkinson’s disease., Mov. Disord., 27, 831, 10.1002/mds.24962 · DOI
  119. Reed, 2019, The role of monogenic genes in idiopathic Parkinson’s disease., Neurobiol. Dis., 124, 230, 10.1016/j.nbd.2018.11.012 · DOI
  120. Reeve, 2014, Ageing and Parkinson’s disease: why is advancing age the biggest risk factor?, Ageing Res. Rev., 14, 19, 10.1016/j.arr.2014.01.004 · DOI
  121. Ren, 2019, G2019S variation in LRRK2: an ideal model for the study of Parkinson’s disease?, Front. Hum. Neurosci., 13, 10.3389/fnhum.2019.00306 · DOI
  122. Rivero-Ríos, 2019, The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A., J. Biol. Chem., 294, 4738, 10.1074/jbc.RA118.005008 · DOI · Paper page
  123. Robak, 2017, Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease., Brain, 140, 3191, 10.1093/brain/awx285 · DOI · Paper page
  124. Roberts, 2003, Piecemeal microautophagy of nucleus in Saccharomyces cerevisiae., Mol. Biol. Cell, 14, 129, 10.1091/mbc.e02-08-0483 · DOI · Paper page
  125. Roberts, 2015, Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain., Brain, 138, 1642, 10.1093/brain/awv040 · DOI
  126. Rocha, 2015, Progressive decline of glucocerebrosidase in aging and Parkinson’s disease., Ann. Clin. Transl. Neurol., 2, 433, 10.1002/acn3.177 · DOI
  127. Rojas, 2008, Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7., J. Cell Biol., 183, 513, 10.1083/jcb.200804048 · DOI · Paper page
  128. Rothaug, 2014, LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance., Proc. Natl. Acad. Sci. U.S.A, 111, 15573, 10.1073/pnas.1405700111 · DOI
  129. Saha, 2015, Mutations in LRRK2 potentiate age-related impairment of autophagic flux., Mol. Neurodegener., 10, 10.1186/s13024-015-0022-y · DOI
  130. Sahu, 2011, Microautophagy of cytosolic proteins by late endosomes., Dev. Cell, 20, 131, 10.1016/j.devcel.2010.12.003 · DOI · Paper page
  131. Saito, 2004, Aberrant phosphorylation of α-synuclein in human niemann-pick type C1 disease., J. Neuropathol. Exp. Neurol., 63, 323, 10.1093/jnen/63.4.323 · DOI
  132. Sánchez-Danés, 2012, Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease., EMBO Mol. Med., 4, 380, 10.1002/emmm.201200215 · DOI
  133. Sanyal, 2020, Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition., Mov. Disord., 10.1002/mds.27994 · DOI
  134. Schapansky, 2018, Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons., Neurobiol. Dis., 111, 26, 10.1016/j.nbd.2017.12.005 · DOI
  135. Schneider, 2017, Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature., Mov. Disord., 32, 1504, 10.1002/mds.27193 · DOI
  136. Segrest, 1992, The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function., J. Lipid Res., 33, 141, 10.1016/S0022-2275(20)41536-6 · DOI
  137. Seo, 2017, AMPK and vacuole-associated Atg14p orchestrate μ-lipophagy for energy production and long-term survival under glucose starvation., eLife, 6, 10.7554/eLife.21690 · DOI
  138. Shachar, 2011, Lysosomal storage disorders and Parkinson’s disease: gaucher disease and beyond., Mov. Disord., 26, 1593, 10.1002/mds.23774 · DOI
  139. Shahmoradian, 2019, Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes., Nat. Neurosci., 22, 1099, 10.1038/s41593-019-0423-2 · DOI
  140. Sherer, 2003, Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation., Exp. Neurol., 179, 9, 10.1006/exnr.2002.8072 · DOI
  141. Smith, 2014, Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease., J. Pathol., 232, 509, 10.1002/path.4328 · DOI
  142. Smith, 2006, Kinase activity of mutant LRRK2 mediates neuronal toxicity., Nat. Neurosci., 9, 1231, 10.1038/nn1776 · DOI · Paper page
  143. Spencer, 2009, Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson’s and Lewy body diseases., J. Neurosci, 29, 13578, 10.1523/JNEUROSCI.4390-09.2009 · DOI · Paper page
  144. Sridhar, 2013, The lipid kinase PI4KIIIβ preserves lysosomal identity., EMBO J., 32, 324, 10.1038/emboj.2012.341 · DOI · Paper page
  145. Stefanis, 2019, How is alpha-synuclein cleared from the cell?, J. Neurochem., 150, 577, 10.1111/jnc.14704 · DOI
  146. Steger, 2017, Systematic proteomic analysis of LRRK2-mediated rab GTPase phosphorylation establishes a connection to ciliogenesis., eLife, 6, 10.7554/eLife.31012 · DOI · Paper page
  147. Steger, 2016, Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases., eLife, 5, 10.7554/eLife.12813 · DOI · Paper page
  148. Surmeier, 2017, Parkinson’s disease is not simply a prion disorder., J. Neurosci., 37, 9799, 10.1523/JNEUROSCI.1787-16.2017 · DOI
  149. Suzuki, 2007, Neuronal and glial accumulation of α- and β-synucleins in human lipidoses., Acta Neuropathol., 114, 481, 10.1007/s00401-007-0264-z · DOI
  150. Taylor, 2020, Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson’s disease., Curr. Opin. Cell Biol., 63, 102, 10.1016/j.ceb.2020.01.001 · DOI · Paper page
  151. Tekirdag, 2018, Chaperone-mediated autophagy and endosomal microautophagy: joint by a chaperone., J. Biol. Chem., 293, 5414, 10.1074/jbc.R117.818237 · DOI
  152. Thirstrup, 2017, Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells., Sci. Rep., 7, 10.1038/s41598-017-10501-z · DOI
  153. Tokuda, 2010, Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease., Neurology, 75, 1766, 10.1212/WNL.0b013e3181fd613b · DOI
  154. Tsuji, 2017, Niemann-pick type C proteins promote microautophagy by expanding raft-like membrane domains in the yeast vacuole., eLife, 6, 10.7554/eLife.25960 · DOI
  155. Twohig, 2019, α-synuclein in the pathophysiology of Alzheimer’s disease., Mol. Neurodegener., 14, 10.1186/s13024-019-0320-x · DOI · Paper page
  156. Vaibhava, 2012, Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17., J. Cell Sci., 125, 5026, 10.1242/jcs.102327 · DOI
  157. Vanier, 1983, Biochemical studies in niemann-pick disease I. Major sphingolipids of liver and spleen., Biochim. Biophys. Acta, 750, 178, 10.1016/0005-2760(83)90218-7 · DOI
  158. Verhoeven, 2003, Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy., Am. J. Hum. Genet, 72, 722, 10.1086/367847 · DOI
  159. Walkley, 2009, Secondary lipid accumulation in lysosomal disease., Biochim. Biophys. Acta, 1793, 726, 10.1016/j.bbamcr.2008.11.014 · DOI
  160. Wallings, 2019, LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function., Hum. Mol. Genet., 28, 2696, 10.1093/hmg/ddz088 · DOI
  161. Walter, 2019, Neural stem cells of Parkinson’s disease patients exhibit aberrant mitochondrial morphology and functionality., Stem Cell Rep., 12, 878, 10.1016/j.stemcr.2019.03.004 · DOI
  162. West, 2017, Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease., Exp. Neurol., 298, 236, 10.1016/j.expneurol.2017.07.019 · DOI
  163. West, 2005, Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity., Proc. Natl. Acad. Sci. U.S.A., 102, 16842, 10.1073/pnas.0507360102 · DOI · Paper page
  164. West, 2007, Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity., Hum. Mol. Genet., 16, 223, 10.1093/hmg/ddl471 · DOI · Paper page
  165. Xu, 2010, Multi-system disorders of glycosphingolipid and ganglioside metabolism., J. Lipid Res., 51, 1643, 10.1194/jlr.R003996 · DOI
  166. Yakhine-Diop, 2014, G2019S LRRK2 mutant fibroblasts from Parkinson’s disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy., Toxicology, 324, 1, 10.1016/j.tox.2014.07.001 · DOI
  167. Yasuda, 2016, Mon1-Ccz1 activates Rab7 only on late endosomes and dissociates from the lysosome in mammalian cells., J. Cell Sci., 129, 329, 10.1242/jcs.178095 · DOI
  168. Yoshimura, 2010, Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors., J. Cell Biol., 191, 367, 10.1083/jcb.201008051 · DOI · Paper page
  169. Ysselstein, 2019, LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients., Nat. Commun., 10, 10.1038/s41467-019-13413-w · DOI
  170. Zhang, 2018, Tau pathology in Parkinson’s disease., Front. Neurol., 9, 10.3389/fneur.2018.00809 · DOI
  171. Zhang, 2005, TBC domain family, member 15 is a novel mammalian Rab GTPase-activating protein with substrate preference for Rab7., Biochem. Biophys. Res. Commun., 335, 154, 10.1016/j.bbrc.2005.07.070 · DOI
  172. Zunke, 2018, Reversible conformational conversion of α-synuclein into toxic assemblies by glucosylceramide., Neuron, 97, 92, 10.1016/j.neuron.2017.12.012 · DOI

Cited by

Sorted by citations

Metadata

Authors
Rivero-Ríos, P., Romo-Lozano, M., Fasiczka, R., Naaldijk, Y., & Hilfiker, S.
Venue
Frontiers in Neuroscience
Publisher
Frontiers Media SA
Published
2020-06-04
Volume
14
ISSN
1662-453X
DOI
10.3389/fnins.2020.00556
PMC
PMC7287096
Cited by
31
References
16
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Michael J. Fox Foundation for Parkinson's Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review